Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
I'm PortAI, I can summarize articles.
Bluejay Diagnostics Inc. has announced a $4.5 million private placement priced at-the-market under Nasdaq rules. The company will sell 2,250,000 shares of common stock and Series F warrants to purchase up to 4,500,000 shares at $2.00 per share. The Series F warrants have an exercise price of $1.75 and will expire in 5.5 years. The proceeds will support FDA approval efforts, R&D activities, and general working capital. Rodman and Renshaw LLC is the exclusive placement agent for this offering.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments